DrugDashboards

carisoprodol

carisoprodol · CARISOPRODOL 250 mg/1 · Tablet · Oral · Rising Pharma Holdings, Inc.

NDC 16571-0780-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

27 companies supply this market — deep enough that no single failure threatens the supply. The generic price has fallen 34% in a year, to $0.3975 per unit — and generics that get this cheap tend to get abandoned rather than defended. The brand (Soma) runs $11.39 per unit 170× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.3975per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.1590per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.5234per TABweighted avg manufacturer price $0.2991 · Jul 1, 2026132% of what pharmacies pay — higher than 76% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50Sep 2021Sep 2026$0.3975
53 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$11.92
#90 count
$35.77

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$52,011
1,279 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

8Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 29% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for carisoprodol (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $12.18 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA040792
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of carisoprodol (Tablet)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackCARISOPRODOL 250 mg/1Jul 15, 2026Sep 3, 2026
Direct_RxCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPCARISOPRODOL 350 mg/1Jul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
DirectrxCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Granulation Technology, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Medsource PharmaceuticalsCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Oxford Pharmaceuticals, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
St. Mary's Medical Park PharmacyCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Vensun Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Viatris Specialty LLCCARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Viatris Specialty LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCCARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCCARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Wilshire Pharmaceuticals, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Sep 2, 2026
Wilshire Pharmaceuticals, Inc.CARISOPRODOL 250 mg/1Jul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Aug 31, 2026
Remedyrepack Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Aug 31, 2026
NuCare Pharmaceuticals,Inc.CARISOPRODOL 350 mg/1Jul 15, 2026Aug 29, 2026
Aurobindo Pharma LimitedCARISOPRODOL 250 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "carisoprodol — NDC 16571-0780-01," retrieved September 3, 2026, https://drugdashboards.com/drug/16571078001.

Free to cite with attribution — see how the data is put together.